Browsing by Author Griggs, Kim

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2012Aquaporin 1 is an independent prognostic factor in pleural malignant mesotheliomaKao, Steven; McCaughan, Brian; Armstrong, Nicola; Condon, Bridget; Griggs, Kim; Henderson, Douglas W; Klebe, Sonja; Maltby, Sarah; Wilson, Alan; Concord Clinical School: Medicine; Central Clinical School: SurgeryAquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma, Cancer, vol.118, 11, 2012,pp 2952-2961
2012Association of Genetic Variants in the TMCO1 Gene with Clinical Parameters Related to Glaucoma and Characterization of the Protein in the EyeMitchell, Paul; Burdon, Kathryn P; Casson, Robert; Chidlow, Glyn; Craig, Jamie E.; Crawford, April; Danoy, Patrick; Dave, Alpana; Dimasi, David P; Griggs, Kim; Hewitt, Alex; Javadiyan, Shahrbanou; Klebe, Sonja; Landers, John; Mackey, David A.; Martin, Sarah; Sharma, Shiwani; Wood, John P M; Western Clinical School: Westmead Millennium InstituteAssociation of Genetic Variants in the TMCO1 Gene with Clinical Parameters Related to Glaucoma and Characterization of the Protein in the Eye, Investigative Ophthalmology and Visual Science, vol.53, 8, 2012,pp 4917-4925
2015Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo modelReid, Glen; Cheng, Yuen; Driml, Jack; Griggs, Kim; Henderson, Douglas; Klebe, Sonja; Concord Clinical School: MedicineBlockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model, Disease Markers, vol.2015, N/A, 2015,pp 1-9
2015Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisEdelman, John (James); Kao, Steven; Kirschner, Michaela; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Cheng, YuenYee; Dong, Yawen; Emily, Pulford; et al, Various; Griggs, Kim; Grusch, Michael; Hoda, Mir Alireza; Hyland, Rebecca; Klikovits, Thomas; Laszlo, Viktoria; Rozsas, Anita; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteFibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis, British Journal of Cancer, vol.113, 6, 2015,pp 963-969
2014An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesotheliomaCheng, Yuen Yee; Gattani, S; Kao, Steven; Kirschner, Michaela; Linton, Anthony; McCaughan, Brian; Reid, Glen; Srikaran, Subothini; van Zandwijk, Nico; Griggs, Kim; Klebe, Sonja; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: ANZAC Research InstituteAn RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma, British Journal of Cancer, vol.110, 2, 2014,pp 510-519
2011Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesotheliomaClarke, Stephen; Kao, Steven; McCaughan, Brian; van Zandwijk, Nico; Vardy, Janette; Armstrong, Nicola; Burn, Juliet; Griggs, Kim; Henderson, Douglas W; Klebe, Sonja; Lee, Kenneth; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineValidation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma, Pathology, vol.43, 4, 2011,pp 313-317